Key Takeaways
- General Mills is recalling roughly 736,000 Pillsbury bread rolls because they may contain glass fragments.
- The recall covers two product lines: “Hard Roll Dough” (3,080 cases × 180 rolls) and “Kaiser Roll Dough” (1,260 cases × 144 rolls).
- Individual rolls weigh 2.25 oz (hard) or 2.5 oz (Kaiser) and have “Better if used by” dates of Oct 12, 2026 and Oct 13, 2026, respectively.
- Affected cases were shipped to 18 states, mainly to food‑service operators rather than retail consumers.
- The recall was initiated on June 19, 2024, after the FDA posted a notice earlier this week warning of potential foreign material (glass).
- General Mills also markets well‑known brands such as Betty Crocker, Cheerios, Lucky Charms and Nature Valley.
General Mills announced a voluntary recall of nearly three‑quarters of a million Pillsbury frozen bread rolls after discovering that the products might contain glass shards. The U.S. Food and Drug Administration posted the recall notice earlier this week, classifying the issue as “potential foreign material (glass).” The affected items fall under two SKUs: Pillsbury Bread Rolls “Hard Roll Dough” and Pillsbury Bread Rolls “Kaiser Roll Dough.”
For the Hard Roll Dough, the recall encompasses 3,080 cases, each case holding 180 individual rolls. With each roll weighing 2.25 oz, this translates to a total of 554,400 rolls. The Kaiser Roll Dough portion involves 1,260 cases, each containing 144 rolls of 2.5 oz, amounting to 181,440 rolls. Combined, the two lines represent approximately 735,840 rolls, which the company rounds to “nearly 736,000.”
The recall notice specifies the “Better if used by” dates as October 12, 2026 for the Hard Roll Dough and October 13, 2026 for the Kaiser Roll Dough. These dates are far in the future, indicating that the product has a long shelf life when kept frozen, which is typical for bakery‑type dough intended for commercial use. The product descriptions on General Mills’ website emphasize ease of preparation for back‑of‑house operations: “Thaw, proof and bake for easy back‑of‑house preparation and low labor.” This wording confirms that the rolls are primarily sold to restaurants, cafeterias, hotels, and other food‑service establishments rather than directly to grocery‑store shoppers.
Geographically, the recalled cases were distributed across a broad swath of the United States. The states listed in the notice are Arkansas, California, Florida, Georgia, Indiana, Louisiana, Maine, Missouri, New Mexico, New York, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, and Wyoming. The wide reach reflects the national scale of General Mills’ food‑service supply chain.
General Mills initiated the recall on June 19, 2024, after internal quality checks flagged the possible presence of glass. The company promptly notified the FDA, which then published the recall notice. In the statement, General Mills urged customers who have the affected product to dispose of it or return it to the place of purchase for a full refund. The firm also advised any consumers who experience adverse effects after consuming the rolls to seek medical attention and report the incident to the FDA’s MedWatch program.
While the recall is limited to these two Pillsbury roll varieties, it is worth noting that General Mills’ portfolio includes many household names. Besides Pillsbury, the corporation owns Betty Crocker (baking mixes and frostings), Cheerios (breakfast cereal), Lucky Charms (marshmallow‑laden cereal), and Nature Valley (granola bars and snacks). The recall does not extend to those brands, but the incident underscores the importance of rigorous quality‑control measures across all product lines, especially for items destined for institutional kitchens where large batches are prepared and served.
In summary, the recall involves a substantial volume of frozen bread rolls that may contain glass, affecting food‑service operators in eighteen states. The product’s long “better if used by” dates and its orientation toward commercial use explain why the recall reaches far into the future and targets businesses rather than individual shoppers. General Mills’ swift action, in coordination with the FDA, aims to mitigate any health risk and maintain consumer confidence in its broader brand portfolio.